Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 503401 - 503420 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 30MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 30MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 45MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 45MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PfizerInc. |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PfizerInc. |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PfizerInc. |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 200MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 200MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 250MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 250MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 150MG PELLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 150MG PELLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 20MG PELLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 20MG PELLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 50MG PELLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED01) crizotinib (adm: O) | XALKORI 50MG PELLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01ED04) brigatinib (adm: O) | ALUNBRIG 180MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01ED04) brigatinib (adm: O) | ALUNBRIG 180MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaceuticalsAmerica,Inc. |
Pages
